ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0614

Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data

Krati Chauhan1 and James T. Rosenbaum2, 1Southern Illinois University - School of Medicine, Springfield, IL, 2Departments of Ophthalmology, Medicine, and Cell Biology, Oregon Health & Sciences University and Chair Emeritus, Legacy Devers Eye Institute, Portland, OR

Meeting: ACR Convergence 2021

Keywords: Access to care, Administrative Data, Disparities, Eye Disorders, Medicare

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Healthcare Disparities in Rheumatology Poster (0594–0622)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Health care utilization has an impact on disease progression and outcome in rheumatologic care. Disparities based on race, sex, education and income level affect care of our patients. Ocular inflammatory diseases increase disease burden in many rheumatologic conditions. We have compared Medicare and Intelligent Research in Sight (IRIS) data to identify similarities and differences in healthcare utilization for ocular inflammatory and infectious diseases. IRIS is a clinical registry, assembled by the American Academy of Ophthalmology. Registry uses Health Insurance Portability and Accountability Act (HIPAA) compliant methods to collect data directly from participating Ophthalmology practices’ individual electronic medical record (EMR) systems. In 2018, the registry collected data from more than 90% of ophthalmologists nationally

Methods: We have used Medicare and IRIS data available through National Vision and Eye Health Surveillance System (VEHSS). Medicare data are collected from research identifiable files obtained through the Center for Medicare and Medicaid Services (CMS) and include all fee for service beneficiaries.

VEHSS uses ICD-10 codes to identify ocular disorders and organizes them into two level categorization, which are category and subgroup. Each code is categorized in one subgroup and multiple subgroups are combined to form a category. The inflammatory and infectious eye disease category includes subgroups of ocular inflammatory conditions, lacrimal system and orbital inflammation, keratitis, conjunctivitis, eyelid inflammation and infection and endophthalmitis.

Utilization for the the Medicare and IRIS data was compared for the years 2016-2017. We have identified the impact of utilization for both the databases when stratified by sex and race alone and when stratified by race and sex together.

Results: Females have higher utilization across all races for the inflammatory and infectious eye diseases for both Medicare and IRIS data, for both 2016 and 2017. Asians have higher utilization for both males and females in both the databases. Whereas Hispanics have second highest utilization for Medicare data and North American Natives have second highest utilization for the IRIS data for both the years 2016-2017.

When the Medicare and IRIS databases are stratified by both race and sex, Asian females have the highest utilization, followed by Asian males for both the databases for both the years.

For the IRIS database, North American females have the second highest utilization followed by the North American males for both the years. For Medicare database, other females and other males have the second highest utilization followed by the Hispanic females and Hispanic males.

Conclusion: Comparing the Medicare and the IRIS data provides significant complimentary information on eye care utilization for inflammatory and infectious eye diseases. Females, Asians, Hispanics and Native Americans having higher utilization for both the years 2016-2017. This may be due to higher disease prevalence or higher service utilization. Further studies are needed to clarify this and to help in making informed policy decisions.

Medicare and IRIS Utilization Stratified by Race

Medicare and IRIS Utilization by Race and Sex: 2016

Medicare and IRIS Utilization by Race and Sex 2017


Disclosures: K. Chauhan, None; J. Rosenbaum, AbbVie, 2, UCB, 2, Novartis, 2, Gilead, 2, Corvus, 2, Roivant, 2, Revolo, 2, Neoleukin, 2, Affibody, 2, Santen, 2, Celgene, 2, Bristol Myers, 2, Pfizer, 5, Horizon, 5, UpToDate, 9.

To cite this abstract in AMA style:

Chauhan K, Rosenbaum J. Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/sex-and-race-based-utilization-of-healthcare-for-ocular-inflammation-and-infection-comparing-the-results-from-the-medicare-and-the-iris-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-and-race-based-utilization-of-healthcare-for-ocular-inflammation-and-infection-comparing-the-results-from-the-medicare-and-the-iris-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology